April 30, 2018
With an average survival rate of 16 months, glioblastoma is the most common and deadly type of brain cancer, accounting...
April 29, 2018
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018
Canntab Therapeutics Limited (CSE: PILL) (formerly Telferscot Resources Inc.) ("Canntab" or the "Company") is pleased to announce that it continues...
April 19, 2018
With Q1 2018 officially in the books, here the Investing News Network takes a look back at what some of...
April 18, 2018
With Q1 2018 behind us, here the Investing News Network looks back on some of the biggest trends of the...
April 12, 2018
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before.
April 1, 2018
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.